Bromocriptine Mesylate (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the Bromocriptine Mesylate drug offered from KAISER FOUNDATION HOSPITALS. This Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
NON-PROPRIETARY NAME: | bromocriptine mesylate |
SUBSTANCE NAME: | BROMOCRIPTINE MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-10-10 |
END MARKETING DATE: | 0000-00-00 |
Bromocriptine Mesylate HUMAN PRESCRIPTION DRUG Details:
Item Description | Bromocriptine Mesylate from KAISER FOUNDATION HOSPITALS |
LABELER NAME: | KAISER FOUNDATION HOSPITALS |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(mg/1) |
START MARKETING DATE: | 2014-10-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0179-0165_c803f04c-c4e0-4120-88e8-86a721323987 |
PRODUCT NDC: | 0179-0165 |
APPLICATION NUMBER: | ANDA076962 |
Other BROMOCRIPTINE MESYLATE Pharmaceutical Manufacturers / Labelers: